Jane Street
TBPH icon

Jane Street’s Theravance Biopharma TBPH Stock Holding History

Jane Street’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-55,831
Closed -$988K – 12953
2025
Q4 		$1.04M Sell
55,831
-135,966
-71% -$2.26M ﹤0.01% 6033
2025
Q3 		$2.8M Buy
191,797
+149,033
+349% +$1.88M ﹤0.01% 4341
2025
Q2 		$472K Sell
42,764
-98,120
-70% -$954K ﹤0.01% 7031
2025
Q1 		$1.26M Buy
140,884
+88,540
+169% +$824K ﹤0.01% 5145
2024
Q4 		$493K Sell
52,344
-92,231
-64% -$839K ﹤0.01% 6806
2024
Q3 		$1.17M Buy
144,575
+1,640
+1% +$14.2K ﹤0.01% 5584
2024
Q2 		$1.21M Buy
142,935
+109,327
+325% +$987K ﹤0.01% 5413
2024
Q1 		$301K Sell
33,608
-337,909
-91% -$3.13M ﹤0.01% 7559
2023
Q4 		$4.18M Sell
371,517
-87,994
-19% -$886K ﹤0.01% 3122
2023
Q3 		$3.97M Buy
459,511
+33,091
+8% +$319K ﹤0.01% 2948
2023
Q2 		$4.41M Buy
426,420
+303,654
+247% +$3.35M ﹤0.01% 2929
2023
Q1 		$1.33M Sell
122,766
-23,388
-16% -$247K ﹤0.01% 4494
2022
Q4 		$1.64M Sell
146,154
-43,793
-23% -$460K ﹤0.01% 4168
2022
Q3 		$1.93M Buy
189,947
+103,214
+119% +$967K ﹤0.01% 4260
2022
Q2 		$786K Sell
86,733
-36,601
-30% -$337K ﹤0.01% 5925
2022
Q1 		$1.18M Buy
123,334
+70,068
+132% +$687K ﹤0.01% 5786
2021
Q4 		$589K Buy
53,266
+38,820
+269% +$338K ﹤0.01% 6953
2021
Q3 		$107K Buy
+14,446
New +$162K ﹤0.01% 9261
2021
Q2 		– Sell
-14,192
Closed -$290K – 10396
2021
Q1 		$290K Buy
+14,192
New +$270K ﹤0.01% 7749
2020
Q4 		– Sell
-21,140
Closed -$313K – 8106
2020
Q3 		$313K Sell
21,140
-1,197,772
-98% -$22.4M ﹤0.01% 5821
2020
Q2 		$25.6M Buy
+1,218,912
New +$31.3M 0.02% 631
2018
Q2 		– Sell
-141,329
Closed -$3.43M – 5607
2018
Q1 		$3.43M Buy
+141,329
New +$3.88M 0.01% 1283
2016
Q2 		– Sell
-10,584
Closed -$199K – 4578
2016
Q1 		$199K Buy
+10,584
New +$173K ﹤0.01% 3713

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jane Street's TBPH Position: Q1 2026 in Review

Jane Street sold out of Theravance Biopharma (TBPH) in Q1 2026, closing a stake of 55,831 shares — an estimated $988K sold.

Jane Street first reported a position in TBPH in Q1 2016 and held it in 23 quarters. The position peaked at $25.6M in Q2 2020. 174 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Jane Street reported no remaining Theravance Biopharma position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 55,831 Theravance Biopharma shares in Q1 2026, an estimated $988K.
  • Jane Street first reported a position in Theravance Biopharma in Q1 2016 and held it in 23 quarters.
  • Jane Street's Theravance Biopharma position peaked at $25.6M in Q2 2020.
  • 174 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.